Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia

Osamu Iida(Osaka Police Hospital), Nobuyoshi Azuma(Asahikawa Medical University), Yoshimitsu Soga(Kokura Memorial Hospital), Hiroto Terashi(Asahikawa Medical University), Mitsuyoshi Takahara(The University of Osaka), Akio Kodama(Asahikawa Medical University)
Circulation Cardiovascular Interventions
December 1, 2017
10.1161/circinterventions.117.005531
Cited by 181

Related Papers

Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia
|European Journal of Vascular and Endovascular Surgery|2019|522
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial
|The Lancet|2018|288
Factors Influencing Wound Healing of Critical Ischaemic Foot after Bypass Surgery: Is the Angiosome Important in Selecting Bypass Target Artery?
|European Journal of Vascular and Endovascular Surgery|2012|222